i.v. PCA EA biochemical recurrence (PSA >0.1ng/ml) yes no 45 (42.9%) 60 (57.1%) 79 (42.5%) 107 (57.5%) metastases yes no 5 (4.7%) 101 (95.3%) 14 (7.7%) 169 (92.3%) death yes no 14 (13.6%) 89 (86.4%) 30 (16.6%) 151 (83.4%)

Table 3: Clinical outcome.